This report contains market size and forecasts of PCSK9 Inhibitors in global, including the following market information:
Global PCSK9 Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PCSK9 Inhibitors Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five PCSK9 Inhibitors companies in 2021 (%)
The global PCSK9 Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epatha(Evolocumab) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PCSK9 Inhibitors include Amgen, Eli Lilly, Sanofi, Pfizer, Novartis, Roche, Merck, Alnylam and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PCSK9 Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PCSK9 Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PCSK9 Inhibitors Market Segment Percentages, by Type, 2021 (%)
Epatha(Evolocumab)
Praluent(Alirocumab)
Bococizumab
Others
Global PCSK9 Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PCSK9 Inhibitors Market Segment Percentages, by Application, 2021 (%)
Clinical Application
Drug Development
Other
Global PCSK9 Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PCSK9 Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PCSK9 Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PCSK9 Inhibitors revenues share in global market, 2021 (%)
Key companies PCSK9 Inhibitors sales in global market, 2017-2022 (Estimated), (K Units)
Key companies PCSK9 Inhibitors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Eli Lilly
Sanofi
Pfizer
Novartis
Roche
Merck
Alnylam
AstraZeneca
Affiris
BMS
Ionis Pharmaceuticals
Cyon Therapeutics
Daiichi Sankyo